chr8-30132393-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001100916.2(MBOAT4):c.858C>T(p.Pro286Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00501 in 1,551,660 control chromosomes in the GnomAD database, including 358 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 202 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 156 hom. )
Consequence
MBOAT4
NM_001100916.2 synonymous
NM_001100916.2 synonymous
Scores
15
Clinical Significance
Conservation
PhyloP100: -2.62
Genes affected
MBOAT4 (HGNC:32311): (membrane bound O-acyltransferase domain containing 4) Enables serine O-acyltransferase activity. Involved in peptidyl-serine octanoylation. Predicted to be located in endoplasmic reticulum. Predicted to be active in membrane. Predicted to be integral component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
LEPROTL1 (HGNC:6555): (leptin receptor overlapping transcript like 1) Enables identical protein binding activity. Predicted to be involved in late endosome to vacuole transport via multivesicular body sorting pathway and negative regulation of growth hormone receptor signaling pathway. Predicted to be integral component of membrane. Predicted to be active in endosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0017038882).
BP6
Variant 8-30132393-G-A is Benign according to our data. Variant chr8-30132393-G-A is described in ClinVar as [Benign]. Clinvar id is 784126.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.62 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0905 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0266 AC: 4047AN: 152132Hom.: 199 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4047
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00582 AC: 909AN: 156300 AF XY: 0.00465 show subpopulations
GnomAD2 exomes
AF:
AC:
909
AN:
156300
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00265 AC: 3702AN: 1399410Hom.: 156 Cov.: 34 AF XY: 0.00227 AC XY: 1567AN XY: 690214 show subpopulations
GnomAD4 exome
AF:
AC:
3702
AN:
1399410
Hom.:
Cov.:
34
AF XY:
AC XY:
1567
AN XY:
690214
Gnomad4 AFR exome
AF:
AC:
3075
AN:
31598
Gnomad4 AMR exome
AF:
AC:
181
AN:
35706
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25182
Gnomad4 EAS exome
AF:
AC:
0
AN:
35738
Gnomad4 SAS exome
AF:
AC:
26
AN:
79232
Gnomad4 FIN exome
AF:
AC:
0
AN:
49278
Gnomad4 NFE exome
AF:
AC:
75
AN:
1078976
Gnomad4 Remaining exome
AF:
AC:
328
AN:
58002
Heterozygous variant carriers
0
227
454
681
908
1135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0267 AC: 4072AN: 152250Hom.: 202 Cov.: 32 AF XY: 0.0258 AC XY: 1921AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
4072
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
1921
AN XY:
74440
Gnomad4 AFR
AF:
AC:
0.0929242
AN:
0.0929242
Gnomad4 AMR
AF:
AC:
0.00948705
AN:
0.00948705
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000414594
AN:
0.000414594
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000220543
AN:
0.000220543
Gnomad4 OTH
AF:
AC:
0.0222749
AN:
0.0222749
Heterozygous variant carriers
0
190
380
570
760
950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
113
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
217
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 08, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Gain of MoRF binding (P = 0.0217);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=99/1
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at